Logotype for Bio-Techne Corporation

Bio-Techne (TECH) investor relations material

Bio-Techne Jefferies London Healthcare Conference 2025 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Bio-Techne Corporation
Jefferies London Healthcare Conference 2025 summary20 Nov, 2025

Financial performance and market trends

  • Core growth was up 1% after adjusting for large customer order timing, with overall reported growth at -1%.

  • Large pharma end market showed double-digit growth, contributing 30% of revenues, with broad strength in both the US and Europe.

  • Biotech funding improved, leading to faster conversion of spend into programs and instrument sales, especially among mid-sized, well-funded companies.

  • Stabilization observed in academic and biotech markets, with China returning to solid growth.

  • US academic market showed sequential improvement, with grant outlays shifting toward oncology and neurological research.

Strategic positioning and industry dynamics

  • Deglobalization and reshoring trends are expected to increase local manufacturing, benefiting life science tool spending through duplicated QA/QC and validation needs.

  • The company is well positioned in the US, Europe, and Asia, with plans to continue gaining market share as regional manufacturing expands.

  • No significant changes in the competitive landscape for cell therapy; the company maintains a leadership position in complex protein manufacturing.

  • Promotional activity in protein sciences focused on targeted grants to seed high-value programs, increasing customer base from 550 to 700.

Innovation and product development

  • 8% of revenues are reinvested in R&D, driving innovation across four growth verticals.

  • Recent launches include ProPax protein packaging, ELA ultra-sensitive cartridge, LEO high-capacity Western Blot instrument, and Proximity Scope for spatial biology.

  • AI-driven protein design enables creation of ultra-specific, heat-stable, and patentable proteins, supporting premium pricing.

  • New molecular diagnostics products include an exosome-based ESR1 breast cancer marker and an Oxford Nanopore-based genetic testing kit.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Bio-Techne earnings date

Logotype for Bio-Techne Corporation
Evercore ISI 8th Annual HealthCONx Conference2 Dec, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Bio-Techne earnings date

Logotype for Bio-Techne Corporation
Evercore ISI 8th Annual HealthCONx Conference2 Dec, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Bio-Techne Corporation develops, manufactures, and sells life sciences research and clinical diagnostic products. The company’s portfolio includes proteins, antibodies, reagents, and diagnostic instruments supporting academic research, biopharmaceutical production, and clinical testing. Bio-Techne serves scientists and healthcare providers globally. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage